Predict your next investment

Angel Investor (Individual)

See what CB Insights has to offer

Investments

1

About Sokratis Papafloratos

Sokratis Papafloratos Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Sokratis Papafloratos News

Numan Raises $20M in Debt; Closes $60.1M Series B Round

Feb 7, 2022

Numan, a UK-based digital platform for men’s health, raised $20M in debt funding from Kreos Capital and closed a $60.1M Series B funding round.The round was led by White Star Capital, with participation from Novator, VNV Global, and Anthemis Exponential.The new funding coincides with launch of blood testing proposition in the UK, as Numan looks to double headcount in 2022.The company also plans to use the funding to launch new therapeutic areas in men’s health and expand internationally.Led by Sokratis Papafloratos, CEO & founder, Numan provides a digital health clinic for men that offers direct-to-consumer health products and pharmaceuticals. Disclaimer: This story is auto-aggregated & summarized by a computer program and has not been created by StartupAround.

Sokratis Papafloratos Investments

1 Investments

Sokratis Papafloratos has made 1 investments. Their latest investment was in Calm as part of their Angel on February 2, 2013.

CBI Logo

Sokratis Papafloratos Investments Activity

investments chart

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.